Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Directorate Change

4 Jul 2025 12:49

RNS Number : 8278P
Ceiba Investments Limited
04 July 2025
 

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

APPOINTMENT OF NON-EXECUTIVE DIRECTORS

 

Further to RNS announcement number 4152G released by the Company on 28 April 2025, the Company is pleased to announce the appointment of Dena Bellamy, Mary Dunphy and Robin Smith as independent, non-executive directors of the Company with effect from 3 July 2025.

 

Dena Bellamy is an experienced corporate finance professional with over 25 years of experience in investment banking. After completing her Ph.D., she embarked on a career that saw her work at international financial institutions including Rothschild, Merrill Lynch, and Commerzbank. Dena has provided strategic advice on M&A transactions, IPOs, and bond issuance to clients in a range of sectors, including real estate and infrastructure. Dena has held board director roles in both public and private companies, including Biofarma Innovations, a joint venture with BioCubaFarma, the Cuban state-owned pharmaceutical company. She has also recently spent a number of years working on the establishment of a new international investment bank in Cuba.

 

Mary Dunphy, a law graduate from Trinity College, has held numerous positions as a Chairperson and Board member of Private, Listed and Global Not-for-profits organisations and on a pro bono for international and national charities. Most recently she has chaired two Nasdaq listed companies. Previously she was a Global Equity Partner / Senior Managing Director at both Accenture & Teneo (Global Board & C-Suite Advisory). She worked with C-Suite teams, boards and VC / PE investors of high profile and FTSE100 organisations; on defining and delivering double digit EBITDA and valuation improvements. Mary was the Global CEO of CoderDojo: a charity she activated and led in 65 countries. Mary is an experienced keynote speaker at global events including at the World Economic Forum at Davos, The Web Summit, SouthxSouthWest, Salesforce World Tour & Dreamforce, EU Parliament and Buckingham Palace. She is also a multi award recipient and media presenter.

 

Robin Smith is a Fellow of the Chartered Association of Certified Accountants (FCCA) who was educated in Guernsey, studied accountancy in the UK and trained professionally with Deloitte, Haskins & Sells in London. He is also a member of the Society of Trust and Estate Practitioners (STEP). From 1984 until 2024, Mr Smith held senior positions with three fiduciary groups, first with Havelet and Nerine where he performed a variety of roles including Company Secretary and Group Finance Director with board appointments on their principal Guernsey based fiduciary and fund operations. Most recently until February 2024 he was Managing Director of the Praxis Guernsey Fiduciary business until his retirement in February 2024. He is a non-executive Director of a UK Charity, Servol Community Services Limited and is a Non-Executive Director of each of Darwin Property Investment Management Limited and Darwin Alternative Investment Management Limited who between them manage three Guernsey Open Ended Class B Collective Investment Schemes. 

 

Details of all directorships held by each of Dena, Mary and Robin in other publicly quoted companies are as follows:

 

Director

Current Directorships

Previous Directorships

Dena Bellamy

Equipmake Holdings plc

n/a

Mary Dunphy

n/a

Mashup Ireland AB

Robin Smith

n/a

n/a

 

Dena, Mary and Robin will also be appointed as members of the Company's Audit Committee, Nomination Committee and Management Engagement Committee.

 

John Herring, Chairman of the Company, commented:

 

"We are extremely pleased to welcome Dena, Mary and Robin on to the Board. Each of them brings significant skills, knowledge and a fresh perspective to the Board and we look forward to working with them going forward."

 

This announcement has been made in accordance with the requirements of 6.4.6 and 6.48 of the UK Listing Rules.

 

A further announcement regarding the successor of the role of Senior Independent Director which was previously fulfilled by Keith Corbin who retired from the Board at the Company's Annual General Meeting on 3 July 2025, will be made in due course.

 

For further information, please contact:

 

John Herring

 

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Patrick Weaver (Corporate Finance)

 

James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

 

 

www.ceibainvest.com

 

 

END OF ANNOUNCEMENT

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUACMUPAGGC
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.